DALLAS, TX is a ten year old company that has developed exclusive and proprietary high-powered therapeutic BioTech L3aser? non-invasive pain management protocols, training and certification for laser technicians, the creation of BioTech pain management centers to be developed nationwide, patents for SHBAN? Antimicrobial Solution, and BioBody Nutriceutical Products.

Since November 2003, over 48,500 combined therapeutic laser medical procedures have been performed. Four-year combined unaudited billed revenues and product sales for all centers exceeds $5,000,000.

Currently BioTech operates 4 affiliated Pain Management & Wellness Centers in Dallas, Kansas City (Overland Park), Albuquerque and Santa Fe, NM. Our Los Angeles center is being relocated at this time and additional affiliated centers in Los Angeles, Dallas, New York City, Miami and Chicago are planned for a series of centers this year.

What sets BioTech apart is the patent protected high-powered therapeutic FDA 510(k) cleared medical lasers that provide heating the patient feels healing their body with light. Most competitors use "cold lasers" that operate with 5,000 to 12,000 times less power. Patients cannot feel a cold laser.

Back pain, carpal tunnel, shoulder, knees and hip pain, plus 90 more ailments, including arthritis, can be quickly and safely treated to temporarily reduce and/or relieve pain. The laser may also temporarily increase blood circulation and may be used to promote relaxation of muscle tissue.

BioTech has an experienced management team. Keith Houser, Chairman/CEO has over 32 years of both private and public corporate management experience. Charles R. Crane, MD, President has over 35 years of medical practice and board certification in physical and sports medicine as well as specialized training in pain management. Kim Peralta-Jacobs, D.C., is Secretary with over 12 years' experience as a practicing chiropractor. James Nairne, CFO is a Canadian chartered accountant with over 32 years' experience as an accountant.

Safe Harbor for Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. This is not an offer to buy or sell any security. The FDA has not evaluated SHBAN.

Contact: Investor Relations 972-274-5533 www.biotechmedics.com

BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Mar 2025 to Apr 2025 Click Here for more BioTech Medics (PK) Charts.
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Apr 2024 to Apr 2025 Click Here for more BioTech Medics (PK) Charts.